434 related articles for article (PubMed ID: 24728044)
1. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
2. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
[TBL] [Abstract][Full Text] [Related]
3. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
4. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
Fang JH; Yu XM; Zhang SH; Yang Y
J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
[TBL] [Abstract][Full Text] [Related]
6. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
[TBL] [Abstract][Full Text] [Related]
7. Co-infection between genotypes of the human papillomavirus and
Escarcega-Tame MA; López-Hurtado M; Escobedo-Guerra MR; Reyes-Maldonado E; Castro-Escarpulli G; Guerra-Infante FM
Int J STD AIDS; 2020 Nov; 31(13):1255-1262. PubMed ID: 32998641
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.
Waisberg MG; Ribeiro AC; Candido WM; Medeiros PB; Matsuzaki CN; Beldi MC; Tacla M; Caiaffa-Filho HH; Bonfa E; Silva CA
Rheumatol Int; 2015 Mar; 35(3):459-63. PubMed ID: 25348220
[TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
10. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
[TBL] [Abstract][Full Text] [Related]
11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
13. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine women.
Golijow CD; Abba MC; Mourón SA; Laguens RM; Dulout FN; Smith JS
Gynecol Oncol; 2005 Jan; 96(1):181-6. PubMed ID: 15589598
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina.
Deluca GD; Basiletti J; Schelover E; Vásquez ND; Alonso JM; Marín HM; Lucero RH; Picconi MA
Braz J Infect Dis; 2011; 15(6):567-72. PubMed ID: 22218516
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of
Martinelli M; Musumeci R; Rizzo A; Muresu N; Piana A; Sotgiu G; Landoni F; Cocuzza C
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31514378
[No Abstract] [Full Text] [Related]
17. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
Fehér E; Szalmás A
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
[TBL] [Abstract][Full Text] [Related]
19. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
20. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Castle PE; Glass AG; Rush BB; Scott DR; Wentzensen N; Gage JC; Buckland J; Rydzak G; Lorincz AT; Wacholder S
J Clin Oncol; 2012 Sep; 30(25):3044-50. PubMed ID: 22851570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
